These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6748459)

  • 1. [Rifampicin-induced nonresponsiveness to corticosteroid treatment in systemic lupus erythematosus: a case report].
    Itoh H; Fujihira T; Harada S; Kido M; Kajiki A; Nakashima Y; Kuroiwa A
    Kekkaku; 1984 Apr; 59(4):303-8. PubMed ID: 6748459
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin induced non-responsiveness to steroids in bronchial asthma.
    Jain NK; Madan A; Jhamaria JP; Sharma TN; Mathur DK; Singh DP
    Indian J Chest Dis Allied Sci; 1989; 31(4):271-4. PubMed ID: 2638668
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus].
    Rass IT; Borisov IA; Nikishova TA; Sura VV
    Ter Arkh; 1977; 49(8):110-5. PubMed ID: 929380
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of "steroid" tuberculosis in a patient with systemic lupus erythematosus, simulating metastatic tumor].
    Marga OIa; Kuplaĭs VP; Guberman SL
    Probl Tuberk; 1984 Dec; (12):65-6. PubMed ID: 6522389
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes of the indicators of hemostasis during corticosteroid treatment of systemic lupus erythematosus].
    Iakumova NIa; Ivanova AV; Sukhanov AA
    Vopr Revm; 1975; (1):63-5. PubMed ID: 1121805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Discontinuous corticosteroid treatment of systemic lupus erythematosus].
    Tareeva IE
    Klin Med (Mosk); 1972 Jun; 50(6):95-9. PubMed ID: 5086287
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin.
    Bergrem H; Refvem OK
    Proc Eur Dial Transplant Assoc; 1983; 19():552-7. PubMed ID: 6878255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulminant pneumonitis developed during the middle-dose corticosteroid therapy in systemic lupus erythematosus.
    Oku H; Okamura M; Amatsu K; Ohe A; Kato N; Kanayama Y; Horiguchi T; Inoue T
    Osaka City Med J; 1980; 26(2):145-9. PubMed ID: 7290651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reversible dementia and polyneuritis in an elderly woman: a case of late-onset disseminated lupus erythematosus].
    Manto M; Badot V; Koulischer D; Henriet M; Guillaume B; Jacquy J
    Acta Neurol Belg; 1993; 93(3):139-45. PubMed ID: 8346702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rifampicin-induced resistance to prednisolone treatment in collagen disease--a pharmacokinetic study].
    Kawai S; Ichikawa Y; Homma M
    Ryumachi; 1984 Feb; 24(1):32-7. PubMed ID: 6740415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modification of systemic lupus erythematosus in connection with steroid hormone therapy (clinico-morphological parallels)].
    Vinogradova OM; Potekseva MA
    Sov Med; 1966 Aug; 29(8):25-33. PubMed ID: 5991389
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin reduces effectiveness and bioavailability of prednisolone.
    McAllister WA; Thompson PJ; Al-Habet SM; Rogers HJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):923-5. PubMed ID: 6403136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choreoathetosis and seizures associated with systemic lupus erythematosus--a case report.
    Chew SK; Tan BY
    Singapore Med J; 1983 Feb; 24(1):56-8. PubMed ID: 6867767
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic lupus erythematosus during isoniazid therapy.
    Guleria R; Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1990; 32(1):55-8. PubMed ID: 2269498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of streptomycin-induced lupus].
    Toyoshima M; Taniguchi M; Imokawa S; Nakazawa K; Sato A; Hayakawa H; Chida K
    Kekkaku; 1993 Apr; 68(4):319-23. PubMed ID: 8497122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.